Monopar Therapeutics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
MNPR Nasdaq 2836 www.monopartx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Monopar Therapeutics Inc.

What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 - Dec 22nd, 2025 8:11 am
Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? - Nov 22nd, 2025 5:47 am
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments - Nov 13th, 2025 6:00 am
Coinbase upgraded, Six Flags downgraded: Wall Street's top analyst calls - Nov 10th, 2025 7:39 am
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025 - Nov 9th, 2025 7:00 am
Does Monopar Therapeutics (MNPR) Have the Potential to Rally 42.46% as Wall Street Analysts Expect? - Oct 21st, 2025 7:55 am
How the Narrative Around AstraZeneca Is Shifting Amid New Risks and Pipeline Developments - Oct 18th, 2025 12:07 pm
Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy - Oct 16th, 2025 2:33 pm
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025 - Oct 15th, 2025 6:00 am
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - Sep 23rd, 2025 9:08 pm
Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients - Sep 23rd, 2025 9:07 pm
CoreWeave upgraded, Lululemon downgraded: Wall Street's top analyst calls - Sep 23rd, 2025 7:40 am
Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout - Sep 15th, 2025 2:08 pm
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting - Sep 14th, 2025 6:00 am
Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting - Sep 3rd, 2025 6:00 am
US High Growth Tech Stocks To Watch Now - Sep 1st, 2025 11:38 am
Exploring 3 High Growth Tech Stocks In The US Market - Sep 1st, 2025 5:38 am
High Growth Tech Stocks To Watch In US August 2025 - Aug 29th, 2025 11:37 am
US High Growth Tech Stocks to Watch This August 2025 - Aug 29th, 2025 5:38 am
High Growth Tech Stocks In The US For August 2025 - Aug 28th, 2025 5:41 am